Basaglar® KwikPen for Diabetes

Basaglar® is a long-acting insulin glargine injection supplied in the prefilled KwikPen. It provides steady, 24-hour basal blood sugar control for people with diabetes. At CanadianInsulin, you get Canadian pricing from Canada with US delivery from Canada, so you can review the Basaglar KwikPen price and options if you pay without insurance.

Every CanadianInsulin order is prescription-checked with your clinic and dispensed by a licensed Canadian pharmacy.

What Basaglar® Is and How It Works

Basaglar is insulin glargine 100 units/mL. It is a long-acting (basal) insulin designed to release slowly after a subcutaneous injection. The basal profile helps control fasting and between‑meal glucose. Many patients use Basaglar once daily at the same time each day. It is not for intravenous use, and you should not mix or dilute it with other insulins or solutions.

Basaglar begins working within hours and provides activity for up to 24 hours in many patients. Your prescriber will tailor your plan and adjust the dose to meet your glucose targets. Basaglar is used as a component of a full diabetes treatment plan that may include diet, activity, and other diabetes medicines.

Who Basaglar® Is For

Basaglar is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes and in adults with type 2 diabetes who need basal insulin. It is not appropriate during episodes of hypoglycemia or for the treatment of diabetic ketoacidosis. Do not use if you have had a hypersensitivity reaction to insulin glargine or any component of the formulation.

Use caution if you have kidney or liver problems, are pregnant or breastfeeding, or are older. Your clinician will determine if Basaglar fits your treatment plan.

Dosage and Usage

Dosing is individualized. Follow your clinician’s directions and the official prescribing information.

• Administer subcutaneously once daily, at the same time each day.
• Inject into the abdomen, thigh, buttock, or upper arm. Rotate sites to reduce skin changes.
• Type 1 diabetes: Basaglar provides the basal portion of a basal-bolus plan. The basal share is often about one‑third to one‑half of the total daily insulin, but your prescriber will set the regimen.
• Type 2 diabetes: Common initial doses include 10 units once daily or about 0.2 units/kg once daily, with titration based on fasting glucose, as directed by your clinician.
• Switching from another basal insulin: Your prescriber will determine appropriate conversion and follow-up monitoring.

Always read the Instructions for Use that come with the pen. If you need a practical walkthrough, see the step-by-step guide in How To Use Basaglar Kwikpen.

Strengths and Forms

• KwikPen prefilled pen: 100 units/mL (U-100), 3 mL per pen (300 units).
• Common retail pack: 5 pens (5 x 3 mL) per box. Needles are not included.

Availability may vary by lot and dispensing pharmacy. For similar devices, browse Long Acting Insulin Pens.

Missed Dose and Timing

If you miss a dose, take it as soon as you remember that day. If it is close to your next dose, skip the missed dose and resume your regular schedule. Do not take extra insulin to make up for a missed dose. Monitor your blood glucose more often and follow your clinician’s guidance.

Storage and Travel Basics

• Unopened pens: Refrigerate at 2°C to 8°C (36°F to 46°F). Do not freeze. If frozen, discard.
• In-use pen: Store at room temperature below 30°C (86°F). Do not refrigerate a pen in use. Keep away from heat and light.
• Use an in-use pen within 28 days; then discard, even if it still contains insulin.
• Keep the cap on to protect from light. Do not store a pen with the needle attached.
• When traveling, keep your pen with you in a temperature-safe case. Do not leave insulin in a parked car or luggage hold.

Pen Handling and Sharps Disposal

• Check the label to confirm the medicine and strength.
• Attach a new sterile pen needle before each injection.
• Prime the pen per the Instructions for Use (often 2 units) until you see insulin at the tip.
• Dial your dose. Insert the needle into the skin. Press and hold the injection button fully. Count slowly (for example, to 10) before removing the needle.
• Remove and discard the needle immediately after the injection.
• Do not share pens or needles. Do not reuse needles.
• Place used needles in an FDA-cleared sharps container or a puncture-resistant household container. Follow local rules for sharps disposal.

For technique tips and visuals, review How To Use Basaglar Kwikpen.

Benefits

• Once-daily basal insulin designed for 24-hour coverage.
• Prefilled KwikPen with simple dialing in 1‑unit increments.
• No need to mix before use.
• Can be combined with mealtime insulin or non-insulin agents as directed.

Side Effects and Safety

Common effects include:

• Hypoglycemia (low blood sugar)
• Injection-site reactions such as redness, pain, or itching
• Skin changes at the injection site (lipodystrophy or localized thickening)
• Weight gain
• Peripheral edema (fluid retention)
• Mild rash or itching

Serious risks can include severe hypoglycemia, severe allergic reactions, hypokalemia (low potassium), and fluid retention that may worsen heart failure when used with thiazolidinediones. Seek medical help for signs of severe allergy, significant swelling or shortness of breath, confusion, seizures, or loss of consciousness. Learn more in Basaglar® KwikPen Uses.

Hypoglycemia risk may be higher if you also use other glucose‑lowering medicines. Have a plan for recognizing and treating low blood sugar, and keep fast‑acting carbohydrates available.

Drug Interactions and Cautions

Many medicines can raise or lower your insulin needs. Examples include corticosteroids, some diuretics, thyroid medicines, estrogens or progestins, atypical antipsychotics, protease inhibitors, and certain HIV or hepatitis treatments. Alcohol can increase the risk of hypoglycemia and should be used carefully.

Beta‑blockers may blunt warning signs of hypoglycemia such as tremor or rapid heartbeat. Thiazolidinediones used with insulin can cause or worsen edema and heart failure. Discuss your full medication list with your clinician and pharmacist. For background on combination therapy, see Common Diabetes Medications.

Use Basaglar only as a subcutaneous injection. Do not use in an insulin pump. Do not mix or dilute.

What to Expect Over Time

After you start or adjust Basaglar, fasting glucose typically changes over several days as you titrate with your clinician’s plan. Many people look for steadier overnight readings and fewer daytime swings once a suitable basal dose is reached. A1C may improve over months when basal insulin is optimized alongside diet, activity, and other therapy.

Expect periodic dose reviews. Glucose targets or doses may change with weight shifts, illness, new medicines, or changes in activity or diet.

Compare With Alternatives

Other long‑acting basal insulins may be considered if your prescriber recommends a change. Options include Lantus® Solostar Pens and Levemir® Penfill. For a head‑to‑head overview, see Basaglar® Vs Levemir.

Pricing and Access

CanadianInsulin lists the Basaglar KwikPen price with Canadian pricing and US shipping. You can compare the Basaglar KwikPen cost, including the Basaglar insulin pens price for common packs. Many shoppers review Basaglar 100 units/mL KwikPen price details and the Basaglar KwikPen 5 x 3 mL pens price before checkout. If you need a Basaglar KwikPen price from Canada that ships to the US, you can see current options on this page.

If you pay out of pocket, our listings can help you estimate a Basaglar KwikPen cash price and the Basaglar KwikPen without insurance cost. We provide secure, encrypted checkout and prompt, express, cold‑chain shipping when required for temperature control. Looking for seasonal offers? Check our promotions page.

Availability and Substitutions

Availability can vary. If a specific pack is unavailable, your prescriber may recommend an alternative strength, device, or another long‑acting insulin. Your pharmacist will dispense only with a valid prescription that matches your therapy.

Patient Suitability and Cost Saving Tips

Basaglar may be appropriate if you need basal insulin for type 1 or type 2 diabetes and your clinician recommends insulin glargine. It is not for patients with active hypoglycemia or for DKA treatment. Use caution with significant kidney or liver disease, and in pregnancy or breastfeeding as directed by your clinician.

• Ask your prescriber about a 60‑ to 90‑day supply to reduce per‑unit costs.
• Combine items in one shipment when appropriate.
• Set refill reminders so you do not run out unexpectedly.
• Store pens correctly to avoid waste from temperature damage.
• If costs change, discuss alternatives or titration schedules with your clinician.

Questions to Ask Your Clinician

• What fasting glucose target should I use when adjusting my basal insulin?
• Should I start with 10 units once daily or a weight‑based dose?
• How do I adjust my dose during illness or increased activity?
• What signs of hypoglycemia should I watch for with my other medicines?
• Which injection sites are best for me and how should I rotate them?
• What should I do if my schedule changes and I cannot dose at the usual time?
• Is another basal insulin a better fit for my goals or schedule?

Authoritative Sources

• Basaglar Consumer Site
• FDA DailyMed: Basaglar
• Health Canada Drug Product Database

Start your Basaglar KwikPen request with US delivery from Canada and prompt, express, cold‑chain shipping.